Aquacel Ag+
Aquacel Ag+ is a medical device with 8 clinical trials. Currently 1 active trials ongoing. Historical success rate of 83.3%.
Success Metrics
Based on 5 completed trials
Phase Distribution
Phase Distribution
0
Early Stage
0
Mid Stage
3
Late Stage
Highest Phase Reached
Phase 4Trial Status & Enrollment
71.4%
5 of 7 finished
28.6%
2 ended early
1
trials recruiting
8
all time
Detailed Status
Development Timeline
Analytics
Development Status
Trials by Phase
Trials by Status
Recent Activity
Silver in Partial Thickness Pediatric Burns
Comparative Efficacy of Advanced and Traditional Wound Dressings in Post-Operative Orthopedic Care
Comparison of Outcomes Between the Use of Silverlon® Dressing and AQUACEL® AG Dressing Post Cardiac Device Implant
A Randomized Comparison Study of Aquacel Ag and Glucan II as Donor Site Dressings
Comparison of Chitosan and Carboxymethylcellulose Silver Dressings on Burn Wounds in Pediatric and Adult Subjects
Clinical Trials (8)
Silver in Partial Thickness Pediatric Burns
Comparative Efficacy of Advanced and Traditional Wound Dressings in Post-Operative Orthopedic Care
Comparison of Outcomes Between the Use of Silverlon® Dressing and AQUACEL® AG Dressing Post Cardiac Device Implant
A Randomized Comparison Study of Aquacel Ag and Glucan II as Donor Site Dressings
Comparison of Chitosan and Carboxymethylcellulose Silver Dressings on Burn Wounds in Pediatric and Adult Subjects
Compare Aquacel® Ag Versus Mepilex® Border Ag to Manage Bioburden in Leg Ulcers
AQUACEL® Ag Dressing and Urgotul® Silver Dressing on Healing of Chronic Venous Leg Ulcers
Altrazeal™ Versus Aquacel® Ag for Partial Thickness Skin Donor Sites
All 8 trials loaded
Drug Details
- Intervention Type
- DEVICE
- Total Trials
- 8